Independently batch-tested research materials

Phase 1 Configuration – Modular Peptide Systems A+C+E

Product Name: Phase 1 Configuration – Modular Peptide Systems A+C+E Configuration Classification: Initial Framework Configuration Product Information: Configuration Type: Multi-Module Peptide Framework Included Modules: A, C, E Total Modules: 3 System Compatibility: Modular Peptide System Framework Testing Methodology: HPLC-UV-MS Analytical Verification: ISO/IEC 17025 Accredited Laboratory Evaluation Format: Standalone Configuration or Sequential Configuration Framework Analytical Composition: Module A Total Peptide Content: 0.10% Palmitoyl Tripeptide-1 Palmitoyl Tetrapeptide-7 Module C Total Peptide Content: 0.52% Dipeptide-2 Acetyl Tetrapeptide-5 Palmitoyl Tetrapeptide-7 Plus 0.30% Caffeine Module E Total Peptide Content: 0.13% Acetyl Octapeptide-3 (SNAP-8) Tetrapeptide-21 AHK-Cu Cumulative Composition Seven distinct peptides Four structural peptide classes One non-peptide supporting component Product Description: Phase 1 is one of three configurations within PHP’s Modular Peptide System, a modular framework of peptide formulations designed for research evaluation. Configurations represent defined combinations of individual modules (A through E) assembled to provide broader comparative frameworks than standalone module evaluation. Phase 1 combines three distinct modules within a single configuration: the foundational composition (Module A), the precision composition (Module C), and the composite multi-class composition (Module E). Together, these modules establish a broad-spectrum peptide environment spanning multiple peptide classes, concentration profiles, and formulation architectures. Each included module is independently verified through ISO/IEC 17025-accredited analytical testing using HPLC-UV-MS methodology. Batch-specific Certificates of Analysis are available through the COA-Topicals library. Research Framework: Foundational entry point into the Topical System Broadest peptide-class diversity among the three configurations Integrates foundational, localized, and composite compositions Six peptides across four structural classes Suitable for standalone configuration evaluation Phase 1 may be evaluated independently as a continuous comparative framework or sequentially alongside Phase 2 within a structured evaluation protocol. When configurations are sequenced within a 24-hour evaluation cycle, defined separation intervals (typically ~12 hours) between configurations allow the analytical contributions of each to be observed without compositional overlap. Configuration Characteristics: Combines three distinct formulation architectures Includes both single-class and multi-class peptide compositions Incorporates the system’s highest peptide concentration module (Module C) Includes the system’s most analytically complex module (Module E) Establishes the broadest peptide-class diversity available within a single configuration Provides representation across multiple peptide concentration levels Position Within The System: Within the Topical System framework, Phase 1 functions as the initial configuration and serves as the foundational entry point into the modular architecture. By combining Modules A, C, and E, Phase 1 introduces the…

Research areas: Dermal, Hair & Tissue Appearrance

Search the Certificate of Analysis library for batch-specific test documentation.